MAP Pharma (MAPP) Misses Q4 Views by 2c
- Market Wrap: Home Prices Gain at Slower Pace; Twitter Soars in Q2; Ford Opts for Apple
- Twitter, Inc. (TWTR) Posts Q2 EPS of 2c/Share, Beats Views; Guides FY14 Revs Above Expectations
- After-Hours Stock Movers 7/29: (TWTR) (ZLTQ) (X) Higher; (NTRI) (BWLD) (DWA) Lower (more...)
- Amgen, Inc. (AMGN) Tops Q2 EPS by 30c
- Carl Icahn Sells Nearly 4M Family Dollar Stores, Inc. (FDO) Shares
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q4 loss of $0.46, 2 cents worse than the analyst estimate of ($0.44).
You May Also Be Interested In
- UPDATE: Rock-Tenn Co. (RKT) Tops Q3 EPS by 17c
- Spectrum Brands Holdings (SPB) Posts Mixed Q3 Results
- American Tower Corp. (AMT) Tops Q2 EPS by 4c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!